COMP <GO>
BSX vs MMM // DIVIDEND YIELD & FCF PAYOUT SAFETY
Boston Scientific Corporation (NYSE) VS. 3M Company (NYSE) • 15-METRIC TALLY: BSX 8
— MMM 6
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: MMM
LAST: $41.98 (-1.66%) • MKT CAP: $61.87B
dividend-safety
0.00%
LAST: $174.34 (-1.70%) • MKT CAP: $91.65B
dividend-safety
1.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BSX VS. MMM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BSX | MMM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.00% | 39.90% | +29.10 | BSX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 32.90% | -23.70 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 18.1x | -2.30 | BSX | /valuation <GO> |
| Free Cash Flow Yield | 5.91% | 1.52% | +4.39 | BSX | /fcf-yield <GO> |
| Operating Margin | 18.00% | 18.60% | -0.60 | MMM | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 13.00% | +1.00 | BSX | /net-margins <GO> |
| Revenue Growth (YoY) | 19.90% | 1.50% | +18.40 | BSX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 1.70% | -1.70 | MMM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.77 | 4.37 | -1.60 | MMM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | BSX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 62.5 | -19.50 | MMM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.91 | +0.08 | BSX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.5x | 26.2x | -7.70 | BSX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $61.87B | $91.65B | -$29.78B | MMM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BSX REV | MMM REV | BSX GROSS % | MMM GROSS % | BSX FCF | MMM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.07B | $24.95B | 69.0% | 39.9% | $3.66B | $1.40B |
| FY 2024 | $16.75B | $24.57B | 68.6% | 41.2% | $2.65B | $638.0M |
| FY 2023 | $14.24B | $24.61B | — | — | $1.86B | $5.57B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BSX // BETA 0.99
MMM // BETA 0.91